PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

39,980 stories, page 351 of 667

Advanced search
🇯🇵Industrytakeda.comTier 1 · Company source

GAMMAGARD LIQUID ERC Approved for Primary Immunodeficiency

Takeda NewsOriginal source
🇯🇵Industrytakeda.comTier 1 · Company source

FDA Accepts Takeda’s Entyvio BLA

Takeda NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Medicines for Europe calls for Biotech Act reforms to address ‘biosimilar void’

Generics and Biosimilars InitiativeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Once-weekly HIV therapy may offer alternative to daily pills

CIDRAPOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Australian company announces agreement with Lilly to trial lung cancer combination

PharmaDispatchOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Eikon Therapeutics (EIKN US): Synthetic Expert Call Transcript (04 Aug 2026)

SmartkarmaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Can Data Prevent the Next Drug Shortage?

Pharmaceutical CommerceOriginal source
🌍Industryorthofix.comTier 1 · Company source

Carolyn’s Experience with Spine Surgery and Recovery

OrthofixOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Fiercest Women in Life Sciences 2026: Nominations open now

Fierce BiotechOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Q&A: Scoring Drug Supply Chains for Resilience, Not Just Price

Pharmaceutical CommerceOriginal source
🌍Mediaheartsciences.comTier 2 · Direct publisher

Fortitude Completes Acquisition of 12.5 MW Prosser, Nebraska Facility

HeartSciencesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Holland & Knight Health Dose: August 4, 2026

Holland & KnightOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biopharmaceutical PAT market forecast to reach $4.32bn

European Pharmaceutical ReviewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Industry and patient groups divided over EU biotech plans

euractiv.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

New Green Hemp, Inc. (OTC: NGHI) Announces Strategic Vision Following EcoGreen Biotech Acquisition

GlobeNewswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Opus Genetics Completes Enrollment in Phase 3 Trial of Gene Therapy for Inherited Retinal Disease

Eyewire+Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Four strategies for winning, not just reaching, the biotech launch stage

PharmaLiveOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Developing broad-spectrum antiviral drugs for pandemic preparedness

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: NEXT GENERATION TOOLS FOR GENOME-CENTRIC MULTIMODAL DATA INTEGRATION IN PERSONALISED CARDIOVASCULAR MEDICINE

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: VIrtual Twins as tools for personalised clinicAL care

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: European action for the Diagnosis of Early Non-clinical Type 1 diabetes For disease Interception

CORDISOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Chromatography columns market to reach USD 4.22 billion by 2031

Scientist LiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of Shenyang Xingqi Pharmaceutical Co., Ltd. Class A – SZSE:300573

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Amplia Signs Collaboration Agreement With Lilly, Evaluating Narmafotinib Plus Lilly’s Kras G12C Inhibitor, Olomorasib, in Non-small Cell Lung Cancer

mykxlg.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Amplia's two-drug lung cancer trial is planned for late 2026

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Veru Announces Notice of Allowance for Key Methods of Use U.S. Patent for Enobosarm in Combination with Semaglutide for Quality Weight Loss

The Manila TimesOriginal source
🇺🇸Researchnews.nm.orgTier 2 · Direct publisher

Northwestern Memorial Hospital Earns U.S. News Honor Roll Recognition for 15th Consecutive Year

Northwestern MedicineOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Next generation toolbox for greener pharmaceuticals design & manufacturing towards reduced environmental impact

CORDISOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Is CBD Gummies Considered a Drug - View WIMdutmcG

FC BayernOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pathos AI strikes deals with Alphamab and AstraZeneca to build AI-native oncology pipeline

Manufacturing ChemistOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pediatric Dermatology’s Blind Spot: How Arcutis Built a Drug Pipeline Where the Industry Wouldn’t Look

The Clinical Trial VanguardOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

PharmD students explore antioxidants in invasive plants and root tea

Binghamton UniversityOriginal source
🇨🇦Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Needle Kit For Powered Driver

Some lots were manufactured with out-of- tolerance dimensions, and as a result some users have repor...

Health Canada Recalls and Safety AlertsOriginal source
🌍Researchpremier-research.comTier 2 · Direct publisher

Clinical Outsourcing by Design: A More Intentional Approach

Premier ResearchOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

What to Know About the New Wave of Biotech Beauty

Environmental Working GroupOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Longevity Wellness Pharmaceutical Market : Global Industry Analysis and Opportunity Assessment, 2036

Future Market InsightsOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Latigo laces up for $247M IPO to fund non-opioid pain drug rival to Vertex’s Journavx

Fierce BiotechOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AstraZeneca-Bristol Myers: Brace for a Biotech M&A Boom

Barron'sOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AstraZeneca's Bristol Myers Flirtation Exposes the Bargain Between Britain and Its Pharmaceutical Champion

distilledpost.comOriginal source
🌍Industryfidson.comTier 1 · Company source

FIDSON DELIVERS ₦3.6BN DIVIDEND, REAFFIRMS PATH TO BECOMING AFRICA’S LARGEST PHARMA MANUFACTURER

Fidson HealthcareOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Bayer holds guidance as pharma sales flatten in second quarter

The Pharma LetterOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Merck raises sales forecasts

medwatch.comOriginal source
🇺🇸Industryinvestors.abeonatherapeutics.comTier 1 · Company source

CMS Grants New Technology Add-On Payment (NTAP) Status for ZEVASKYN®

Abeona TherapeuticsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

How a Scottish biotech company is turning whisky waste into a sustainable source of omega-3

The Times of IndiaOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Keep Britain Working review update: June 2026

June 2026 update on implementing the independent review of employers' role in tackling health based...

UK Department of Health and Social CareOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ETFs Investing in Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Class H Stocks

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Access expanding for experimental weight loss drug

CBS NewsOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Tick-borne encephalitis: the green book

Tick-borne encephalitis immunisation information for public health professionals, including updates.

UK Health Security AgencyOriginal source
🌍Industrytizianalifesciences.comTier 1 · Company source

Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer

Tiziana Life SciencesOriginal source
🇯🇵Industrynippon-shinyaku.co.jpTier 1 · Company source

「令和8年熊本地震」による災害に対する義援金について

Nippon Shinyaku NewsOriginal source
🇺🇸CROir.labcorp.comTier 3 · Secondary coverage

Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer

Labcorp Drug DevelopmentOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Haixi Pharmaceuticals Advances Oral nAMD Drug HX9428 With U.S. FDA Nod and New China Trial

TipRanksOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

MFN one year on: a review of the 17 TrumpRx deals

The Pharma LetterOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Eli Lilly Retatrutide Early Access Opens to a Small Group of Patients Before FDA Approval

NCHStatsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

Business WireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Replimune’s Melanoma FDA Decision Pending: This Analyst Sees 40% Upside, ‘High Conviction’ For Approval

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Tasrif Pharmaceutical granted second US patent for CD155-targeting antibody developed with Abzena's humanisation and immunogenicity platforms

Manufacturing ChemistOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enrolment concludes in 4Moving Biotech’s Phase IIa trial of 4P004

YahooOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Merck hikes revenue outlook as new drug sales grow, but cuts profit guidance due to deal charges

CNBCOriginal source
🇺🇸Devicesir.idexx.comTier 1 · Company source

IDEXX Laboratories Announces Second Quarter Results

IDEXX LaboratoriesOriginal source